ANO5 and muscular dystrophy: The mass-spectrometry-based proteomic analysis of intramuscular congophilic deposits obtained from ANO5 muscular dystrophy patients confirmed the presence of amyloid chaperone proteins (e.g., serum amyloid P and/or apolipoprotein E) but failed to identify ANO5 within the deposits [4].